✦ LIBER ✦

Characterization of HER2/neu and topoisomerase IIα status by FISH in locally advanced breast cancer

✍ Scribed by Cristina Corzo Contero; Ignacio Tusquets Trias de Bes; Marta Salido Galeote; Josep Maria Corominas Torres; Berta Laquente Saez; Meritxel Bellet Ezquerra; Xavier Fabregat Mayol; Sergio Serrano Figueras; Francesc Solé Ristol

Book ID: 110647285
Publisher: Springer Milan
Year: 2004
Tongue: Spanish
Weight: 180 KB
Volume: 6
Category: Article
ISSN: 1699-048X
DOI: 10.1007/bf02711836

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive value of apoptosis, prolifera

Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIα for anthracycline chemotherapy in locally advanced breast cancer

✍ G. Arpino; D. R. Ciocca; H. Weiss; D. C. Allred; P. Daguerre; L. Vargas-Roig; M. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 202 KB

Intratumoral heterogeneity of HER2/neu a

Intratumoral heterogeneity of HER2/neu and topoisomerase IIα in breast cancer: a case with clonal monosomy 17

✍ Cristina Corzo; Ignacio Tusquets; Marta Suarez; Xavier Fabregat; Marta Salido; F 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Topoisomerase IIα gene status and predic

Topoisomerase IIα gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer

✍ Laura Orlando; Barbara Del Curto; Sara Gandini; Raffaella Ghisini; Elisabetta Pi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Complete pathological response in patien

Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy

✍ Heidy Cedeño; Rafael Araúz; Fernando Cebamanos; Idalmis de Torraza; Ana Porcell 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 135 KB

Characterization of topoisomerase IIα ge

Characterization of topoisomerase IIα gene amplification and deletion in breast cancer

✍ Tero A.H. Järvinen; Minna Tanner; Maarit Bärlund; Åke Borg; Jorma Isola 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

Topoisomerase II␣ (TOP2A) is a key enzyme in DNA replication and a molecular target for many important anticancer drugs. TOP2A is amplified or deleted together with amplification of the closely located ERBB2/HER-2/neu oncogene in breast cancer. We characterized the copy number aberrations of TOP2A a

Topoisomerase II-α as a predictive facto

Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancer

✍ Henry L. Gómez; Joseph A. Pinto; Mivael Olivera; Tatiana Vidaurre; Franco D. Doi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 297 KB